RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.3B
AUM Growth
+$879M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
63
New
Increased
Reduced
Closed

Top Buys

1
+$381M
2
+$264M
3
+$71.9M
4
NAMS icon
NewAmsterdam Pharma
NAMS
+$59.5M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$55.5M

Top Sells

1
+$368M
2
+$91M
3
+$62.4M
4
HLVX
HilleVax
HLVX
+$29.1M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$26.7M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$1B 18.92%
11,225,357
+4,268,178
2
$432M 8.16%
6,264,707
+3,828,484
3
$394M 7.44%
7,891,254
+600,000
4
$365M 6.89%
7,856,612
5
$216M 4.08%
11,416,948
6
$152M 2.87%
532,892
7
$142M 2.68%
236,114
8
$134M 2.52%
6,317,990
9
$128M 2.41%
12,245,955
10
$123M 2.33%
7,236,454
11
$107M 2.02%
9,000,000
+5,000,000
12
$105M 1.98%
12,297,721
-1,083,333
13
$103M 1.94%
8,670,644
14
$101M 1.91%
31,544,806
15
$100M 1.89%
3,853,867
16
$93.6M 1.77%
5,676,067
+160,000
17
$93.2M 1.76%
7,809,852
+769,230
18
$87.9M 1.66%
3,052,796
19
$76M 1.43%
6,416,147
+416,666
20
$72.7M 1.37%
8,131,952
21
$71.9M 1.36%
+1,000,000
22
$71.2M 1.34%
6,416,998
23
$70.3M 1.33%
22,748,880
24
$66.3M 1.25%
5,587,333
+6,172
25
$62.6M 1.18%
17,202,009
1
2 3